Marantz Unveils Two New Reference-Quality Home Theater Components
Designed to join and complement the award-winning AV 10 pre-amp, AMP 10 power amp and CINEMA 30 AVR product family, the AV 20 and AMP 20 expand the variety of system configurations Marantz's high-end product range can support. Both new units are manufactured at the brand's premium factory, the Shirakawa Audio Works in Japan, and have been meticulously honed and refined by a Marantz Sound Master (a select group of experts within Marantz who are considered to have a particularly high level of listening expertise and judgment they can apply to tuning premium products).
The AV 20 Pre-Amp and AMP 20 power amp.
Photo: Marantz
The AV 20 and AMP 20 both sport the latest iteration of Marantz's iconic 'porthole display' design, together with selectable side illumination, applied to an uncompromising build quality based on a multi-layer, copper-heavy chassis. The new devices' remote controls are made from aluminium, too, as well as offering button backlighting to make them easy to use in dark rooms. Let's get next into the specifics of each model.
The AV 20 carries the latest and most powerful Analog Devices SHARC Dual-core DSP chipset, partnered with uncompromising 32-bit two-channel DACs with dedicated jitter reduction.
This ensures that the AV 20 can precisely decode and process every possible form of incoming audio technology, including the most high-resolution stereo formats and every current form of immersive audio, including Dolby Atmos, IMAX Enhanced, DTS:X Pro and AURO-3D.
The AV 20's premium processing system has been combined with the Audyssey MultEQ XT32 advanced room optimization system, which automatically calibrates sound to take into account your sound system's speaker sizes, speaker distances, level adjustment and many more factors besides. All with a focus, of course, on making sure the AV 20 is able to adapt its audio mastery to as wide a range of speakers and listening environments as possible.
Detail of the Marantz AV 20 Pre-Amp.
Photo: Marantz
Marantz has also equipped the AV 20 with Dirac Live Room Correction plus the Dirac Live Bass Control, enabling you to integrate up to four separated and fully optimized subwoofers into your sound system. Plus, for the first time in a Marantz product, the AV 20 will eventually (following an upcoming firmware update) carry the Dirac Live Active Room Treatment (ARC) technology that's claimed to create an unprecedentedly cohesive and tonally consistent listening experience.
The AV 20 carries seven HDMI inputs all capable of supporting video feeds up to 8K/60Hz or 4K/120Hz, as well as multiple analog and digital inputs and an expansive range of custom installation-optimized features that enable it to adapt to pretty much any scale of set up, from relatively small media rooms to large home theater installations.
The AV 20's discrete HDAM SA-3 preamplifier stage feeds up to 13.4 channels using either RCA or XLR outputs and, finally, the AV 20 supports the latest HEOS multi-room platform, making it as easy as possible to access content streamed through Roon, Spotify Connect, TIDAL Connect, Qobuz Connect, AirPlay 2 and Bluetooth.
Finally, the AV 20 uses a fold-down front panel on its fascia to hide its relatively less-used controls, to retain that distinctive premium Marantz porthole look.
Summary of key features:
* SHARC dual-core DSP with 32-bit two-channel DACs
* Timeless design with the iconic Marantz porthole display and modern high-definition on-screen display
* 8K support for x7 HDMI inputs with x3 HDMI outputs
* Support for Dolby Atmos™, IMAX Enhanced™, DTS:X Pro™ and AURO 3D™
* Audyssey MultEQ XT32 advanced room optimization included, plus Dirac Live calibration, including Bass Control and Active Room Treatment options, available at extra cost
* Access to streaming services via HEOS®, Spotify Connect, TIDAL Connect, Qobuz Connect, Roon Ready, AirPlay 2, Bluetooth and more, all built-in
* 12 x 200W Power Amplifier, with bi-amping and 400W BTL mode available
Detail of the Marantz AMP 20.
Photo: Marantz
The AMP 20 is configured to deliver up to 12 channels of power with 200W per channel (8ohms, 1kHz, THD 0.05% with two channels driven). It also allows users to reconfigure pairs of 200W amp channels into bridged-tied-load (BTL) outputs, delivering up to six channels of 400W if you're lucky enough to have a speaker system that might benefit from that. Or you can opt to bi-amp up to six speakers, with both XLR and RCA inputs available.
Other examples of how the AMP 20 might be used are as a powerful amplifier upgrade for owners of Marantz's CINEMA 30 AVR, or as a complement to AV 10 preamplifiers, where fewer channels of power are required. (Similarly, AV 20 buyers could, say, opt to buy the 16-channel AMP 10 Power Amplifier instead of the AMP 20 if they require more than the 12 channels of power offered by the AMP 20.)
The Marantz AV20 and AMP 20 are both available to buy from today from selected retailers, with each product available for $6,500 in the U.S., €5,500 in Europe and £4,750 in the U.K.
——
Related reading
Kaleidescape Launches New Entry-Level Movie Player
Samsung Adds New 3D Sound Technology To 2025 TV And Soundbar Range
Hisense Unveils New Home Theater Audio System Specifically Designed For King-Sized TVs
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Doosan Fuel Cell begins mass production of fuel cell power systems using Ceres technology
Doosan Fuel Cell Factory Major milestone for Ceres and Doosan partnership Products will target rapidly growing AI/data centre and commercial power markets HORSHAM, United Kingdom, July 28, 2025 (GLOBE NEWSWIRE) -- Ceres Power Holdings plc (CWR.L, 'Ceres' or the 'Company'), a leading developer of clean energy technology, and the Doosan Corporation announce that Doosan Fuel Cell has commenced mass market production of fuel cell stacks using Ceres' solid oxide technology. Doosan Fuel Cell will manufacture the stacks and fuel cell power systems at its dedicated factory in South Korea with the ability to produce a combined generational capacity of 50MW of electrical power each year. This commencement of manufacturing marks a significant milestone for Ceres, as Doosan is the first of its strategic licensing partners to enter mass production using its technology. The fuel cells, stacks and power systems that Doosan Fuel Cell produces will be marketed initially to customers in South Korea. The Ceres designed fuel cells will be manufactured in Doosan Fuel Cell's state-of-the-art factory in the province of Jeollabuk-do, South Korea, where construction began in 2022. Its completion marks the world's first Ceres metal supported solid oxide fuel cell and systems facility to come on-stream. Doosan Fuel Cell anticipates the sale of its first solid oxide fuel cell products will occur before the end of 2025. Doosan Fuel Cell will distribute the solid oxide systems, with a primary market focus on applications for stationary distributed power. These include data centres, where the advent of AI processing has caused a spike in power demand that can be met by the deployment of fuel cells. Other uses include the stabilisation of renewables-based power grids and microgrids through peak power production, power systems for buildings, and auxiliary power solutions for marine shipping markets. Phil Caldwell, Chief Executive Officer of Ceres, said: "Fuel cells have a major part to play in meeting the world's rapidly-increasing power demands, developing energy resilience and ensuring decarbonisation. Ceres' solid oxide design is the ideal technology for these applications through its higher efficiency, lower cost and greater robustness than other technologies. Doosan Fuel Cell's commencement of mass manufacturing is a major step in bringing this technology to the world." Doosoon Lee, Chief Executive Officer of Doosan Fuel Cell, said: "Fuel cells, a clean energy solution, are gaining attention as an optimal alternative to various power demands triggered by AI, including data centres. In South Korea, the world's leading fuel cell market, we aim to lead the adoption of advanced SOFCs by leveraging our collaboration with Ceres. By commercialising these technologies and promoting their domestic production, we intend to spearhead the acceleration of the global transition to a decarbonised society through eco-friendly energy solutions in the commercial power market and maritime mobility." For further information visit or contact: Ceres Power Holdings plcPatrick Yau/ Merryl Black Tel: +44 (0)7884 654179Email:investors@ MHP Group (PR Adviser)Reg Hoare/James McFarlane/Matthew Taylor Tel: +44 (0) 7827 662831Email:ceres@ About Ceres Ceres is a leading developer of clean energy technology: fuel cells for power generation and electrolysers for the production of green hydrogen. Its asset-light, licensing model has seen it establish partnerships with some of the world's largest companies, such as Doosan, Delta, Denso, Shell, Weichai and Thermax. Ceres' solid oxide technology supports greater electrification of our energy systems and produces green hydrogen at high efficiencies as a route to decarbonise emissions-intensive industries such as steelmaking, ammonia and future fuels. Ceres is listed on the London Stock Exchange ("LSE") (LSE: CWR) and is classified by the LSE Green Economy Mark, which recognises listed companies that derive more than 50% of their activity from the green economy. Read more on our website or follow us on LinkedIn. About Doosan Fuel Cell. Doosan Fuel Cell is a subsidiary of Doosan Group, which has a history of over 129 years, making it the oldest conglomerate in South Korea. As a leading fuel cell solution provider with proprietary technology for the world's first commercial fuel cell, Doosan Fuel Cell offers hydrogen solutions including PAFC (Phosphoric Acid Fuel Cell) and SOFC (Solid Oxide Fuel Cell). They provide integrated solutions encompassing the design, technology development, manufacturing, installation, operation, and maintenance of key fuel cell technologies such as stacks and systems. Doosan Fuel Cell, which established the world's first and largest hydrogen fuel cell power plant, is expanding its business area beyond stationary power to include mobility through marine models. The company is committed to addressing climate change and achieving Net-Zero. For more details, please visit its website at or follow it on LinkedIn. A photo accompanying this announcement is available at
Bloomberg
10 minutes ago
- Bloomberg
Chinese OpenAI Challenger Zhipu to Unveil New Open-Source Model
Zhipu is releasing its biggest open-source model to date, joining a growing number of Chinese firms ramping up their free artificial intelligence offerings. The startup will release GLM-4.5, an update to its flagship model, as soon as Monday, according to a person familiar with the plan. It's trying to take on OpenAI globally as it looks to stake out a spot in a burgeoning industry and set standards for future advancements.
Associated Press
19 minutes ago
- Associated Press
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Olympus Co-founds Swan EndoSurgical With Revival Healthcare Capital TOKYO - July 28, 2025 ( NEWMEDIAWIRE ) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer, and more fulfilling, today announced the conclusion of an agreement with Revival Healthcare Capital (Revival) to drive advancements in endoluminal robotics. Olympus and Revival will co-found Swan EndoSurgical, a new company dedicated to developing a novel robotic system designed to revolutionize gastrointestinal (GI) patient care in the future. Endoluminal robotics aims to empower more physicians to safely perform innovative techniques, enhancing patient access to treatment options that support safety and improved recovery times. This groundbreaking advancement has the potential to create new and significantly enhanced minimally invasive treatment options for major unmet medical needs by boosting precision and efficiency in procedures addressing ergonomic strain for healthcare professionals. Bob White, Representative Executive Officer, President and Chief Executive Officer at Olympus, commented, 'This partnership marks a significant milestone in our strategic initiative to advance endoluminal robotics. We are excited to enter this collaboration that we expect to play a pivotal role in reshaping the GI market by expanding procedural capabilities for physicians. This will allow the delivery of transformative, organ-sparing care that enhances outcomes for a broad patient population.' For decades, endoscopy - placing a flexible camera into an existing body orifice - has yielded early and accurate diagnoses of conditions such as GI tract cancer. In recent years, specialists, primarily gastroenterologists, have begun performing endoscopic therapeutic procedures, such as cancer resection, by inserting instruments through the endoscope. However, manual endoscopes and their instruments have limitations that make many advanced procedures within the lumen of the GI tract challenging and not widely available globally. The development of an endoluminal robot, with its ability to easily maneuver within the GI tract and deploy flexible arms, provides the opportunity for more patients to benefit from safe and effective procedures, potentially avoiding invasive surgery. This innovation allows for the early, safe, and effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. Furthermore, the technology has the potential for application in numerous other disease areas. Headquartered in the United States, Swan EndoSurgical has assembled a leadership team of highly experienced industry professionals who will drive technical, clinical, and commercial development of the robotic platform. About Swan EndoSurgical Swan EndoSurgical, Inc. is an innovative start-up co-founded by Revival Healthcare Capital and Olympus that is focused on the development of endoluminal surgical robotics with the aim to create effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. For additional information, visit the Company's website at or contact [email protected]. About Revival Healthcare Capital Revival Healthcare Capital is an investment firm focused on the MedTech sector. Revival specializes in transformative external innovation partnerships and other opportunities where its team of experienced operators and investors believes it can provide leadership, resources, and deep sector insights - beyond its capital - to further support companies' growth strategies. For additional information, visit Revival's website at or contact [email protected] . About Olympus At Olympus, we are committed to Our Purpose of making people's lives healthier, safer, and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis, and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit and follow our global X account: @Olympus_Corp. Media contact: Mail: [email protected] Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS]
